Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018681 (
headache
)
56,091
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
500 cases of intracranial tumor confirmed surgically and pathologically were studied. The aim of this study was to see the diagnostic value of
headache
in intracranial tumor. Four problems related to
headache
were studied in 350 cases along with other informations: Relationship between time of
headache
and tumor; Relationship between locality of
headache
and tumor; Relationship between degree of seriousness of
headache
and tumor; Relationship between
headache
and accompanying symptoms and signs. It was pointed out that
headache
is of certain diagnostic value in patients with intracranial tumor.
Zhonghua
Nei
Ke Za Zhi 1992 Feb
PMID:[The diagnostic value of headache in intracranial tumor]. 132 72
Fourteen cases of tuberculous meningitis complicated by moderate or severe hydrocephalus identified by CT are reported. The accumulation and blockage of tuberculous exudate in the basic cisterns and ependymitis in the cerebrospinal drainage pathway are the important pathological features of this disease. There may be a correlation of hydrocephalus with hyponatraemia.
Headache
, vomiting, and impaired consciousness are common symptoms, although a few cases did not show obvious symptoms of raised intracranial tension. The study suggests a relation between the degree of hydrocephalus and the pressure on lumber puncture. If patients with impaired consciousness, especially in the chronic stage show no improvement during medical treatment, ventricular shunt may bring about remarkable improvement.
Zhonghua
Nei
Ke Za Zhi 1989 Apr
PMID:[Tuberculous meningitis with hydrocephalus: a clinical and CT study]. 280 55
The effects of different dosage of PGE1 on hemodynamics, oxygen delivery (DO2), oxygen consumption (VO2) and hemorheology in patients with pulmonary arterial hypertension (PAH) were investigated. In group 1, 10 cases were treated with PGE1 at a dosage of 20ng/kg.min-1, It was found that pulmonary arterial pressure (mPAP) and pulmonary vascular resistance (PVR) decreased by 23.3% and 38.7% respectively, CI and DO2 increased significantly; blood viscosity decreased significantly, but mean arterial pressure (MAP) and PaO2 were not affected. The side effects at such a dosage included flush of skin,
headache
and malaise. In group 2, 8 of the 10 cases were treated with PGE1 at a dosage of 40ng/kg.min-1. It was found that mPAP and PVR decreased by 22% and 40.4% respectively, CI increased significantly, MAP, systemic vascular resistance (SVR) and PaO2 decreased significantly while DO2 and VO2 changed slightly. The side effects at this dosage consisted of those occurring at the dosage of 20ng/kg.min-1 as well as hypotension and tachycardia. These results showed that PGE1 at a dosage of 20ng/kg.min-1 is effective, well-tolerated and yields less side effects.
Zhonghua
Nei
Ke Za Zhi 1993 Sep
PMID:[Effects of different dosage of PGE1 in pulmonary arterial hypertension]. 811 40
A 29-year-old woman was admitted to the Department of Rheumatology, Peking Union Medical College Hospital due to intermittent rashes, fever and
headache
. Palpable purpura were symmetrically distributed on the extremities and trunk. Other manifestations included
headache
with nausea and vomiting. Elevated white blood cell (WBC) count, platelet (PLT) count, erythrocyte sedimentation rate (ESR) and C-reactive protein were the main laboratory findings. Antinuclear antibodies and antineutrophil cytoplasmic antibodies were negative. Examination of the cerebrospinal fluid (CSF) revealed high intracranial pressure, while routine cytology and biochemical tests of CSF were normal. Head MRI scan and PET-CT did not detect remarkable findings. A diagnosis of systemic vasculitis was confirmed by the biopsy of skin lesion which showed inflammatory infiltration of the muscular vessel wall. Combination therapy of corticosteroids and cyclophosphamide lead to a rapid improvement in clinical symptoms and laboratory parameters. The patient was in stable remission till 6 month follow-up.
Zhonghua
Nei
Ke Za Zhi 2016 Jul 01
PMID:[The 451(th) case: intermittent rash, fever and headache]. 2737 2
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized with multiple organ involvements. Acute acalculous cholecystitis(AAC) is an extremely rare manifestation of digestive system involvement in SLE. We reported a case of 32-year-old woman who complained skin rashes for two weeks and stomachache and oliguria for one day. She had rashes at onset, and developed fever, stomachache, hypotension and
headache
. Physical examination at admission indicated blood pressure 76/47 mmHg(1 mmHg=0.133 kPa), heart rate 107 beats/min, warm acra. Murphy's sign was positive. Ultrasound suggested the enlarged gallbladder with surrounding hypoecho band yet no biliary calculi were found. A diagnosis of SLE was made, characteristic with distributive shock at the onset and AAC, complicated with neuropsychiatric lupus and lupus nephritis. She had an acute and severe course of disease, which had been relieved after treatment of high dose glucocorticoid and immunosuppressants. This case arouses clinicians to pay more attention to AAC as a rare form of disease flare in SLE. Early diagnosis of AAC is crucial to a favorable prognosis and in avoid of abdominal surgery.
Zhonghua
Nei
Ke Za Zhi 2016 Sep 01
PMID:[The 452th case: rash, hypotension, abdominal pain and headache]. 2758 89